DIAGNOSTIC UTILITY OF LINEAR EBUS-TBNA IN CENTRALLY LOCATED LUNG TUMORS AND MEDIASTINAL LYMPHADENOPATHY

Main Article Content

Dr Sarthak Jindal
Dr Mahesh Kumar Mahich
Dr Neha Damor
Dr Mahendra Kumar Bainara
Dr Archana MK
Dr Nemi Chand Garg
Dr Jatin Prajapati

Keywords

Linear EBUS-TBNA, Centrally located lung tumors, Mediastinal lymphadenopathy, Lung cancer diagnosis, Mediastinal staging, Endobronchial ultrasound, Diagnostic yield

Abstract

Centrally located lung tumors and mediastinal lymphadenopathy pose diagnostic challenges, especially when conventional bronchoscopy yields inadequate samples. Linear endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) enables real-time sampling of mediastinal and hilar lymph nodes with high diagnostic accuracy. This study evaluates the diagnostic performance, staging utility, and safety of linear EBUS-TBNA in patients with central lung lesions and mediastinal lymphadenopathy.


Methods: A hospital-based cross-sectional observational study was conducted over five months in the Department of Respiratory Medicine, TB & Chest Hospital, Udaipur. A total of 38 patients ≥18 years with centrally located lung tumors or mediastinal lymphadenopathy were enrolled. Patients underwent clinical evaluation, chest radiography, CECT thorax, fibreoptic bronchoscopy, and EBUS-TBNA. Data on demographics, clinical features, radiology, lymph node characteristics, sampling details, histopathology, and complications were analyzed. Diagnostic performance was calculated using sensitivity, specificity, and predictive values. Statistical significance was set at p < 0.05.


Results: Of the 38 patients, 30 were diagnosed with lung carcinoma (24 NSCLC, 6 SCC). The mean age was 63.23 years, and 76.7% were male. Cough (83.3%), hemoptysis (53.3%), and weight loss (53.3%) were the most common symptoms. CECT most frequently identified masses in the right lower lobe (20%), while mediastinal nodes were common at stations 7 (23.3%) and 10R (20%). EBUS-TBNA most frequently sampled station 7 (23.3%). Single-node sampling was performed in 63.3% of cases. Histopathology confirmed NSCLC in 80% and SCC in 20%. EBUS-TBNA demonstrated a diagnostic yield of 84.2%, significantly higher than bronchoscopy (21.1%). Sensitivity, specificity, PPV, and NPV for diagnosing malignancy were 88.8%, 100%, 100%, and 33.3%, respectively. Most patients presented in stage IIIA/IIIB (63.3%). Procedure-related complications were minimal (16.6%), consisting mainly of minor bleeding and mild desaturation, with no major adverse events.


Conclusion: Linear EBUS-TBNA is a highly effective and safe diagnostic modality for centrally located lung tumors and mediastinal lymphadenopathy, offering superior diagnostic yield over bronchoscopy. Its ability to provide simultaneous diagnosis and staging supports its role as a first-line invasive investigation in lung cancer evaluation.

Abstract 0 | PDF Downloads 0

References

1. Verma A, Jeon K, Koh WJ, Suh GY, Chung MP, Kim H, et al. Endobronchial ultrasound guided transbronchial needle aspiration for the diagnosis of central lung parenchymal lesions, Yonsei Medical Journal, 2013 May;54(3):672–8.
2. Boskovic T, Stanic J, Pena-Karan S, Zarogoulidis P, Drevelegas K, Katsikogiannis N, et al. Pneumothorax after transthoracic needle biopsy of lung lesions under CT guidance. Journal Thoracic Disease 2014 Mar;6(1):99–107.
3. Arslan S, Yilmaz A, Bayramgürler B, Uzman O, Nver E, Akkaya E. CT- guided transthoracic fine needle aspiration of pulmonary lesions: accuracy and complications in 294 patients. Med Sci Monit. 2002 Jul;8(7):493–7.
4. Yung RC. Tissue diagnosis of suspected lung Cancer: selecting between bronchoscopy, Transthoracic needle aspiration, and resectional biopsy. Respir Care Clin N Am. 2003 Mar;9(1):51–76.
5. Bhatti HA, Bajwa A, Bhatti JA, Cury J, Shujaat A, Jones L, et al. Diagnostic yield of EBUS-TBNA for the evaluation of centrally located peribronchial pulmonary lesions. Journal of Bronchology and Interventional Pulmonology, 2013 Apr;20(2):107–12.
6. Nakajima T, Yasufuku K, Fujiwara T, Chiyo M, Sekine Y, Shibuya K, Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of intrapulmonary lesions, Journal of Thoracic Oncology, 2008 Sep;3(9):985–8.
7. Piro, R. Fontana, M. Casalini, E. Rossi, L. Simeone, M.S. Ghinassi, F. Ruggiero, P. Pollorsi, C. Taddei, S. Beghe, et al. Safety and Diagnostic Accuracy of the Transnasal Approach for Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration(EBUS-TBNA). Diagnostics 2023; (13):1400-05.
8. Oezkan, F. Eisenmann, S. Darwiche, K. Gassa, A. Carbone, D.P. Merritt, R.E. Kneuertz, et al. Linear Endobronchial Ultrasound in the Era of Personalized Lung Cancer Diagnostics—A Technical Review Journal, 2021; (10):5640-46.
9. Detterbeck FC, Lewis SZ, Diekemper R, Addrizzo-Harris D, Alberts WM. Executive Summary: Diagnosis and management of lung cancer, 3rd ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:7–37.
10. Schmid-Bindert, G.; Jiang, H.; Kähler, G.; Saur, J.; Henzler, T.; Wang, H.; Ren, S.; Zhou, C.; Pilz, L.R. Predicting malignancy in mediastinal lymph nodes by endobronchial ultrasound: A new ultrasound scoring system. Respirology 2012;17:1190–1198.
11. Virginia Pajares, Alfons Torrego, Elisabeth Martínnez-Téllez, Juan Carlos TrujilloReyes, Diagnosis and invasive staging: Non-surgical invasive mediastinal staging- Endobronchial ultrasound, Journal of Clinical and Translational Research, 2020; (12):406-12.
12. Herth FJF, Eberhardt R, Krasnik M, Ernst A. Endobronchial ultrasound guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest 2008;133:887–891.
13. Herth FJF. Nonsurgical staging of the mediastinum: EBUS and EUS. Semin Respir Crit Care Med 2011;32:62–68.
14. Yasufuku K, Nakajima T, Motoori K, Sekine Y, Shibuya K, Hiroshima K, Fujisawa T, et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest 2006;130:710–718.
15. Oki M, Saka H, Kitagawa C, Rapid on-site cytological evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing lung cancer: a randomized study, Respiration Journal , 2013;85(6):486-492.
16. Joohae Kim, Hyo Jae Kang, Sung Ho Moon, Jong Mog Lee, Hyae Young Kim, Geon Kook Lee, Jin Soo Lee, Bin Hwangbo, et al. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer, Respiratory Cancer Treatment Journal 2019;51(4):1488-1499.
17. Zhao H, Xie Z, Zhou ZL, Sui XZ, Wang J, Diagnostic value of endobronchial ultrasound guided transbronchial needle aspiration in intrapulmonary lesions. China Medical Journal, 2013 Nov;126(22):4312–5.
18. Vilmann P, Clementsen PF, Colella S, Siemsen M, De Leyn P, Dumonceau JM, et al. Combined endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancer. European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS). Eur Respir J. 2015 Jul;46(1):40–60.
19. Fujiwara, T.; Yasufuku, K.; Nakajima, T.; Chiyo, M.; Yoshida, S.; Suzuki, M.; Shibuya, K.; Hiroshima, K.; Nakatani, Y.; Yoshino, et al. The utility of sonographic features during endobronchial ultrasound-guided transbronchial needle aspiration for lymph nodes in patients with lung cancer: A standard endobronchial ultrasound image classification system. Chest 2010;138:641–647.
20. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. Journal of Thoracic Oncology. 2009;4(5):568–577.
21. Lee HS, Lee GK, Lee HS, Real time Endobronchial ultrasound guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: How many aspirations per target lymph node station, Chest Journal, 2008;134(2):368-374.
22. Nakajima T, Yasufuku K, Takahashi R, Comparison of 21-gauge and 22-gauge aspiration needle during endobronchial ultrasound-guided transbronchial needle aspiration. Respirology Journal, 2011;16(1):90-94.

23. Piro R, Fontana M, Casalini E, Rossi L, Simeone MS, Ghinassi F, et al. Safety and Diagnostic Accuracy of the Transnasal Approach for Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA). Diagn Basel Switz. 2023 Apr 13;13(8):1405.
24. Goyal N, De S, Chowhan A, Behera AK, Sahu D, Ganga R. Evaluation of Mediastinal Lymphadenopathy in Patients With Non-small Cell Lung Cancer Using Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration. Cureus [Internet]. 2025 [cited 2025 Jun 29];17.
25. Das B, Mittal N, Mendiratta M, Nair V, Gupta V. Utility of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and additional value of cell block in the diagnosis of mediastinal lymphadenopathy: A one year study in a tertiary care hospital in north India. IP Indian J Immunol Respir Med [Internet]. 2019 Jun 28 [cited 2025 Jun 30];4(2):118–22.
26. Kumar BS, Abhijit M, Debasis D, Ghoshal AG, Kumar DS. Clinico-pathological profile of lung cancer in a tertiary medical centre in India: Analysis of 266 cases.
27. Mohan A, Garg A, Gupta A, Sahu S, Choudhari C, Vashistha V, et al. Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center. Lung India Off Organ Indian Chest Soc [Internet]. 2020 [cited 2025 Jun 30];37(3):190–7.
28. Buccheri G, Ferrigno D. Lung cancer: clinical presentation and specialist referral time. Eur Respir J. 2004 Dec;24(6):898–904.
29. Prevalence of Lung Cancer with a History of Tuberculosis. ResearchGate [Internet]. [cited 2025 Jun 30].
30. Mahishi N, Bala K, Malik P, Ranjan P, Kumar A, Soneja M, et al. The burden of tuberculosis among patients with non-small cell lung carcinoma in a tertiary care center. Indian J Med Microbiol [Internet]. 2024 Nov 1 [cited 2025 Jun 30];52:100729.
31. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer. 2003 Mar 1;103(6):792–802.
32. Humans IWG on the E of CR to. Tobacco Smoke and Involuntary Smoking. International Agency for Research on Cancer; 2004.
33. Fehringer G, Brenner DR, Zhang ZF, Lee YCA, Matsuo K, Ito H, et al. Alcohol and Lung Cancer Risk Among Never Smokers: A Pooled Analysis from the International Lung Cancer Consortium and the SYNERGY Study. Int J Cancer [Internet]. 2017 May 1 [cited 2025 Jul 2];140(9):1976–84.
34. Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol. 2008 Jul;9(7):667–75.
35. Saha A, Saha K, Ghosh S, Mitra M, Panchadhyayee P, Sarkar AP. Chest X-ray of Lung Cancer: Association with Pathological Subtypes. J Assoc Chest Physicians [Internet]. 2017 Dec [cited 2025 Jul 2];5(2):76.
36. Gharraf HS, Mehana SM, ElNagar MA. Role of CT in differentiation between subtypes of lung cancer; is it possible? Egypt J Bronchol [Internet]. 2020 Sep 17 [cited 2025 Jul 2];14(1):28.
37. Ciofiac CM, Mămuleanu M, Florescu LM, Gheonea IA. CT Imaging Patterns in Major Histological Types of Lung Cancer. Life [Internet]. 2024 Apr [cited 2025 Jul 2];14(4):462.
38. CT evaluation of mediastinal lymph nodes in lung cancer: influence of the lobar site of the primary neoplasm [Internet]. [cited 2025 Jul 5].
39. Wi S, Kim B, Shin SH, Jhun BW, Yoo H, Jeong B, et al. Clinical utility of EBUS‐TBNA of hilar, interlobar, and lobar lymph nodes in patients with primary lung cancer. Thorac Cancer [Internet]. 2022 Sep [cited 2025 Jul 7];13(17):2507–14.
40. Wang H, Wang J, Liu Y, Wang Y, Zhou Y, Yu D, et al. Clinical values of different specimen preparation methods for the diagnosis of lung cancer by EBUS-TBNA. Diagn Pathol [Internet]. 2024 Apr 19 [cited 2025 Jul 7];19(1):61.
41. Verma A, Jeon K, Koh WJ, Suh GY, Chung MP, Kim H, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of central lung parenchymal lesions. Yonsei Med J. 2013 May 1;54(3):672–8.
42. Navani N, Nankivell M, Lawrence DR, Lock S, Makker H, Baldwin DR, et al. Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial. Lancet Respir Med [Internet]. 2015 Apr [cited 2025 Jul 7];3(4):282–9.
43. Carr IM, Koegelenberg CFN, von Groote-Bidlingmaier F, Mowlana A, Silos K, Haverman T, et al. Blood loss during flexible bronchoscopy: a prospective observational study. Respir Int Rev Thorac Dis. 2012;84(4):312–8.
44. Facciolongo N, Patelli M, Gasparini S, Lazzari Agli L, Salio M, Simonassi C, et al. Incidence of complications in bronchoscopy. Multicentre prospective study of 20,986 bronchoscopies. Monaldi Arch Chest Dis Arch Monaldi Mal Torace. 2009 Mar;71(1):8–14.
45. Jin F, Mu D, Chu D, Fu E, Xie Y, Liu T. Severe complications of bronchoscopy. Respir Int Rev Thorac Dis. 2008;76(4):429–33.
46. Jalil BA, Yasufuku K, Khan AM. Uses, limitations, and complications of endobronchial ultrasound. Proc Bayl Univ Med Cent [Internet]. 2015 Jul [cited 2025 Jul 7];28(3):325–30.
47. Tscheikuna J, Disayabutr S. THE DIAGNOSTIC YIELD OF ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL LUNG BIOPSY IN PULMONARY LESIONS. CHEST [Internet]. 2008 Oct 1 [cited 2025 Jul 8];134(4):96P.
48. Silvestri GA, Bevill BT, Huang J, Brooks M, Choi Y, Kennedy G, et al. An Evaluation of Diagnostic Yield From Bronchoscopy: The Impact of Clinical/Radiographic Factors, Procedure Type, and Degree of Suspicion for Cancer. Chest [Internet]. 2020 Jun 1 [cited 2025 Jul 8];157(6):1656–64.

Most read articles by the same author(s)

<< < 1 2